Does EFAVIRENZ Cause Mobility decreased? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Mobility decreased have been filed in association with EFAVIRENZ (Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate). This represents 0.1% of all adverse event reports for EFAVIRENZ.
5
Reports of Mobility decreased with EFAVIRENZ
0.1%
of all EFAVIRENZ reports
0
Deaths
5
Hospitalizations
How Dangerous Is Mobility decreased From EFAVIRENZ?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EFAVIRENZ. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does EFAVIRENZ Cause?
Virologic failure (916)
Foetal exposure during pregnancy (701)
Drug resistance (654)
Drug interaction (645)
Viral mutation identified (641)
Depression (602)
Pathogen resistance (567)
Maternal exposure during pregnancy (478)
Treatment failure (390)
Immune reconstitution inflammatory syndrome (301)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which EFAVIRENZ Alternatives Have Lower Mobility decreased Risk?
EFAVIRENZ vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL
EFAVIRENZ vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL
EFAVIRENZ vs EFFEXOR
EFAVIRENZ vs EFFIENT
EFAVIRENZ vs EFGARTIGIMOD ALFA